LP157325-4
Maribavir
Active
Description
Maribavir (originally named 1263W94) is an experimental oral antiviral drug candidate licensed by ViroPharma from GlaxoSmithKline in 2003 for the prevention and treatment of human cytomegalovirus (HCMV) disease in hematopoietic stem cell/bone marrow transplant patients. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Wikipedia
Basic Part Properties
- Part Display Name
- Maribavir
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2012-09-14
- Construct for LOINC Short Name
- Maribavir
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP157325-4
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| zh-CN | Chinese (China) | 马立巴韦 Synonyms: 抗病毒药; |
| es-ES | Spanish (Spain) | Maribavir |
| it-IT | Italian (Italy) | Maribavir |
| tr-TR | Turkish (Turkey) | Maribavir |
| ru-RU | Russian (Russian Federation) | Марибавир |
| nl-NL | Dutch (Netherlands) | maribavir |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright